Neutrophil gelatinase-associated lipocalin is a better biomarker than cystatin C for the prediction of imminent acute kidney injury in critically ill patients.

Yegenaga I., Kamis F., BAYDEMİR C., Erdem E., Celebi K., EREN N., ...More

Annals of clinical biochemistry, vol.55, no.2, pp.190-197, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 55 Issue: 2
  • Publication Date: 2018
  • Doi Number: 10.1177/0004563217694051
  • Journal Name: Annals of clinical biochemistry
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.190-197
  • Keywords: Acute kidney injury, neutrophil gelatinase-associated lipocalin, cystatin C, intensive care, ACUTE-RENAL-FAILURE, INFLAMMATORY RESPONSE SYNDROME, INTENSIVE-CARE UNITS, URINARY BIOMARKERS, CARDIAC-SURGERY, SERUM, CLASSIFICATION, DEFINITIONS, DYSFUNCTION, CREATININE
  • Çanakkale Onsekiz Mart University Affiliated: No

Abstract

Aims The prevention of acute kidney injury can be lifesaving for the intensive care unit patients. However, conventional methods are not sufficient for the prediction of the risk of future acute kidney injury. In this study, the promising biomarker, neutrophil gelatinase-associated lipocalin, was compared with cystatin C as an indicator for the risk of future acute kidney injury.